跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,487 条关于
“VS-214”
全部
21,487
临床试验
18,100
药物
1,276
机构
9
资讯
2,102
5个月前
Vasa Therapeutics Partners with Lilly TuneLab to Accelerate AI-Driven CAMKII Inhibitor Development
去年
Pelabresib Plus Ruxolitinib Shows Significant Benefit in Myelofibrosis Patients
6个月前
AdAlta Completes Global Patent Protection for Anti-Fibrotic Drug AD-214 with Canadian Approval
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
去年
Long-term CheckMate 214 Data Highlights Need for Biomarkers in Metastatic RCC Treatment Selection
去年
Perioperative IO/TKI Combo Shows Promise in Renal Cell Carcinoma
去年
Nivolumab Plus Ipilimumab Shows Durable Survival Benefit in Advanced RCC
去年
LEAP-001 Trial: Lenvatinib and Pembrolizumab Combination Fails to Improve Survival in Advanced Endometrial Cancer
25天前
Precipio vs. Biodesix: Diverging Strategies in Specialty Cancer Diagnostics
第 1 页,共 211 页
上一页
下一页